FBT241220P172000
- 0.00
- 0.000.00%
First Trust Exchange Traded Fund Nyse Arca Biotechnology Index Fund Newsroom
Acadia Signs Licensing Deal for Essential Tremor Drug Candidate
Acadia Pharmaceuticals Announces Exclusive License Agreement With Saniona For SAN711; Under The Terms Of The License Agreement, Saniona Will Receive $28M Upfront Plus Potential Milestone Payments Of Up To $582M
Exelixis Provides Regulatory Update Related To Supplemental New Drug Application For Cabozantinib; Alliance For Clinical Trials In Oncology Independent Data And Safety Monitoring Board Recommends Trial Enrollment To Be Stopped
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"
Gilead Acquires Investigational HIV Vaccine From Spanish Biotech Aelix
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
S&P 500, Dow Hit Records Right After Open | Live Stock
Price Over Earnings Overview: Gilead Sciences
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Optimism Over Global Healthcare Sector Rises: Jefferies
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Gilead Sciences Analyst Ratings
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today